Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Spinal Cord Stimulation Devices Market: By Product Type, By Application, Complex Regional Pain Syndrome, Ischemic Pain, and Others), By End User, and Geography
Spinal Cord Stimulation Devices Market size was valued at US$ 2032.4 million in 2023 and is expected to reach US$ 3362 million by 2030, at a CAGR of 9.2% from 2024-2030. Spinal cord stimulation is a treatment that veils torment motions before they reach the mind. A little gadget, like a pacemaker, is embedded in the body to convey electric heartbeats to the Spinal cord. It enables patients to better deal with their incessant torment side effects and reduce the utilization of opioid drugs. It might be an alternative on the off chance that patients endure constant back, leg, or arm torment and have not discovered help with different treatments. The spreading mindfulness about the upsides of spinal cord stimulation for better torment administration by the medicinal services experts additionally pushes the request for a spinal rope incitement framework and drives the worldwide spinal line incitement framework showcase.
The cost viability of the SCS Devices Market when contrasted with other torment administration market medical procedures, expands the request of the spinal string incitement framework and drives the global spinal cord stimulation (SCS) market. However, spinal cord stimulation (SCS) may prompt difficulties, for example, nerve damage, decimating loss of motion, and other minor correctable issues which could hamper the request of the spinal string incitement framework and limit the development of the global Spinal Cord Stimulation Devices Market. The connection of the spinal cord stimulation system with the pacemakers, diathermy, helpful ultrasound, and MRI may bring about unforeseen changes in incitement and prompts the failure of devices, which may likewise limit the request of systems and development of the worldwide spinal cord stimulation system market.
The business has seen a recognizable pattern where organizations are choosing mergers and acquisitions to solidify their market position and extend their item portfolio. M&A is the snappiest strategy to enter new and quickly developing areas in the spinal line stimulators showcase. This technique likewise brings down the hazard connected to spinal string stimulators\' showcase passage. Another advantage of acquisitions is getting the most recent technology. As a few nations, for example, the U.S. move towards the responsible care display, the cost-adequacy of spinal string stimulators is anticipated to assume a noteworthy part amid the gauge time frame. An examination led by specialists at the Department of Neurology at the University of Saskatchewan Canada has demonstrated that spinal line stimulators are significantly more temperate than traditional medicinal administration in the treatment of ceaseless agony.
Study Period
2024-2030Base Year
2023CAGR
9.2%Largest Market
North AmericaFastest Growing Market
Asia-Pacific
Spinal cord stimulation devices occupies significant space in the neurostimulation devices market. The expanding pattern of insignificantly minimally invasive surgery (MIM) is the key factor support the request of the spinal cord stimulation system and drives the global Spinal Cord Stimulation Devices Market.
The inclination of spinal cord stimulation system is expanding over the other regular medications as these medical procedures are by and large less agonizing, helps to fast recovery of disorder and also reduces the operative stress, which also drives the global SCS Devices Market. The spreading awareness about the advantages of spinal cord stimulation system for better pain management by the healthcare professionals, which additionally drives the worldwide spinal string incitement framework showcase.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market Size in 2023 |
US$ 2032.4 million |
Market Size in 2030 |
US$ 3362 million |
Market CAGR |
9.2% |
By product type |
|
By Application |
|
By End User |
|
Download Free Sample Report
Spinal cord stimulation devices market size was valued at US$ 2032.4 million in 2023 and is set to reach US$ 3362 million by 2030 growing at a CAGR of 9.2%.
The spinal cord stimulation devices market key players are Medtronic, Inc. (U.S.), Boston Scientific Corporation (U.S.), Jude Medical, Inc. (U.S.), Synapse Biomedical, Inc. (U.S.), Nevro Corporation (U.S.)
Asia Pacific is the fastest growing region in spinal cord stimulation devices market.
1. Executive Summary |
2. Global Spinal Cord Stimulation Devices Market Introduction |
2.1.Global Spinal Cord Stimulation Devices Market - Taxonomy |
2.2.Global Spinal Cord Stimulation Devices Market - Definitions |
2.2.1.Product Type |
2.2.2. Application |
2.2.3.End Users |
2.2.4.Region |
3. Global Spinal Cord Stimulation Devices Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID-19 on Market |
4. Global Spinal Cord Stimulation Devices Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Spinal Cord Stimulation Devices Market By Product Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
5.1. Rechargeable Devices |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Non-Rechargeable Devices |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
6. Global Spinal Cord Stimulation Devices Market By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
6.1. Failed Back Surgery Syndrome (FBSS) |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Complex Regional Pain Syndrome (CRPS) |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Ischemic Pain |
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Others |
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
7. Global Spinal Cord Stimulation Devices Market By End Users, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
7.1. Hospitals |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Ambulatory Surgical Centers |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Neuro Clinics |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
8. Global Spinal Cord Stimulation Devices Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
8.1. North America |
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia Pacific (APAC) |
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Middle East and Africa (MEA) |
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Latin America |
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9. North America Spinal Cord Stimulation Devices Market,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
9.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Rechargeable Devices |
9.1.2.Non-Rechargeable Devices |
9.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Failed Back Surgery Syndrome (FBSS) |
9.2.2.Complex Regional Pain Syndrome (CRPS) |
9.2.3.Ischemic Pain |
9.2.4.Others |
9.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Hospitals |
9.3.2.Ambulatory Surgical Centers |
9.3.3.Neuro Clinics |
9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1.United States of America (USA) |
9.4.2.Canada |
10. Europe Spinal Cord Stimulation Devices Market,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
10.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Rechargeable Devices |
10.1.2.Non-Rechargeable Devices |
10.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Failed Back Surgery Syndrome (FBSS) |
10.2.2.Complex Regional Pain Syndrome (CRPS) |
10.2.3.Ischemic Pain |
10.2.4.Others |
10.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Hospitals |
10.3.2.Ambulatory Surgical Centers |
10.3.3.Neuro Clinics |
10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Germany |
10.4.2.France |
10.4.3.Italy |
10.4.4.United Kingdom (UK) |
10.4.5.Spain |
10.4.6.Rest of EU |
11. Asia Pacific (APAC) Spinal Cord Stimulation Devices Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Rechargeable Devices |
11.1.2.Non-Rechargeable Devices |
11.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Failed Back Surgery Syndrome (FBSS) |
11.2.2.Complex Regional Pain Syndrome (CRPS) |
11.2.3.Ischemic Pain |
11.2.4.Others |
11.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Hospitals |
11.3.2.Ambulatory Surgical Centers |
11.3.3.Neuro Clinics |
11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.China |
11.4.2.India |
11.4.3.Australia and New Zealand (ANZ) |
11.4.4.Japan |
11.4.5.Rest of APAC |
12. Middle East and Africa (MEA) Spinal Cord Stimulation Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Rechargeable Devices |
12.1.2.Non-Rechargeable Devices |
12.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Failed Back Surgery Syndrome (FBSS) |
12.2.2.Complex Regional Pain Syndrome (CRPS) |
12.2.3.Ischemic Pain |
12.2.4.Others |
12.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Hospitals |
12.3.2.Ambulatory Surgical Centers |
12.3.3.Neuro Clinics |
12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.GCC Countries |
12.4.2.South Africa |
12.4.3.Rest of MEA |
13. Latin America Spinal Cord Stimulation Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Rechargeable Devices |
13.1.2.Non-Rechargeable Devices |
13.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Failed Back Surgery Syndrome (FBSS) |
13.2.2.Complex Regional Pain Syndrome (CRPS) |
13.2.3.Ischemic Pain |
13.2.4.Others |
13.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Hospitals |
13.3.2.Ambulatory Surgical Centers |
13.3.3.Neuro Clinics |
13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Brazil |
13.4.2.Mexico |
13.4.3.Rest of LA |
14. Competition Landscape |
14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
14.2.1.Medtronic, Inc. (U.S.) |
14.2.2.Boston Scientific Corporation (U.S.) |
14.2.3.Jude Medical, Inc. (U.S.) |
14.2.4.Synapse Biomedical, Inc. (U.S.) |
14.2.5.Nevro Corporation (U.S.) |
14.2.6.Neurosigma, Inc. (U.S.) |
14.2.7.Neuropace, Inc. (U.S.) |
14.2.8.Neuronetics, Inc. (U.S.) |
14.2.9.Cyberonics, Inc. (U.S.) |
14.2.10.BioControl Medical (Israel). |
15. Research Methodology |
16. Appendix and Abbreviations |
Key Market Players